Welcome to Crene Biotechnology!

+86-576-88205808

Product :

Rilpivirine

Rilpivirine 500287-72-9
Size Price Stock Quantity
Get Quotation Now Add to Cart Bulk Inquiry
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:Rilpivirine Purity:98% min
CAS NO:500287-72-9 Solubility:DMSO : 50 mg/mL (136.46 mM)
Molecular Formula:C22H18N6 Package:Package according to customer requirements
Molecular Weight:366.419 Storage:Store at -20℃
Quality control
Remarks

Rilpivirine is a pharmaceutical drug, developed by Tibotec, for the treatment of HIV infection. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz. Rilpivirine entered phase III clinical trials in April 2008, and was approved for use in the United States in May 2011. A fixed-dose drug combining rilpivirine with emtricitabine and tenofovir, was approved by the U.S. Food and Drug Administration in August 2011 under the brand name Complera.

 

Properties:

Density: 1.27g/cm3

Boiling Point: 634.1ºC at 760 mmHg

Melting Point: 245ºC

Flash Point: 337.3ºC

Refractive Index: 1.665

 

 

 

Reverse Transcriptase Inhibitors Related Prodcuts:

Tenofovir alafenamide fumarate; Tenofovir alafenamide; Alovudine; Adefovir; Adefovir dipivoxil; Abacavir; Abacavir sulfate; Efavirenz; Lersivirine

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2024 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China